TY  - CONF

T1  - Cost Effectiveness of Nivolumab for Patients with Advanced, Previously Treated Renal Cell Carcinoma in Scotland

JO  - Value in Health

UR  - https://eprints.whiterose.ac.uk/169365/

PY  - 2017/01/01

AU  - Mahon S

AU  - Bullement A

AU  - Willis A

AU  - Sullivan W

AU  - Britton JA

AU  - Cox L

AU  - Tyas D

AU  - Sowdani A

ED  - 

DO  - DOI: 10.1016/j.jval.2017.08.238

PB  - Elsevier BV

VL  - 20

IS  - 9

SP  - A440

EP  - A440

Y2  - 2024/12/22

ER  -